Tumour suppressor p53 inhibits hepatitis C virus replication by inducing E6AP-mediated proteasomal degradation of the viral core protein
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- FEBS LETTERS596(19) · pp.2525 · 2022
- 피인용
- Web of Science 10Scopus 10
- FWCI (Scopus)
- 0.44
- JCR IF
- JCR 2021 3.864
- ISSN
- 0014-5793
저자
- 박지민제1저자Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, 2 Busandaehak Ro 63, Busan 46241, South Korea
- 윤현영Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, 2 Busandaehak Ro 63, Busan 46241, South Korea
- 정유나Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, 2 Busandaehak Ro 63, Busan 46241, South Korea
- 장경립교신저자Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, 2 Busandaehak Ro 63, Busan 46241, South Korea
초록
The tumour suppressor p53 has been implicated in the host defence system against hepatitis C virus (HCV) infection, although the detailed mechanism remains unknown. Here, we found that p53 inhibits HCV replication by downregulating HCV Core protein levels in human hepatoma cells. For this effect, p53 potentiated the role of E6-associated protein (E6AP) as an E3 ligase to induce ubiquitination and proteasomal degradation of HCV Core. Specifically, p53 facilitated the binding of E6AP to HCV Core through direct interactions with the two proteins. In addition, E6AP failed to induce ubiquitination of HCV Core in the absence of p53, suggesting that p53 increases the E3 ligase activity of E6AP in a triple complex consisting of p53, E6AP and HCV Core.
키워드
coreE6-associated proteinhepatitis C virusp53ubiquitinationEXPRESSIONUBIQUITINATIONCANCERE6-APE6APONCOPROTEINLIGASE
식별자
- Scopus EID
- 2-s2.0-85135625321
- WoS UID
- 000837473800001



로그인
연구물 목록으로